Stocks, Market Update, Insider Trading and More: West Pharma, Chevron, Swiss Life Asset Management, and Others

West Pharmaceutical Services disclosed a cyberattack. Swiss Life Asset Management, Securian Asset Management, and other companies made stock holdings changes. Investors wait on West Pharma's damage assessment, and Chevron faces a shareholder proposal vote on May 27.

West Pharmaceutical Services (WST) has announced a cyberattack on May 7, which compromised data and systems, but its operational impact remains uncertain. The company's shares declined 2.02%. Meanwhile, the stock market continues to witness shifts in holdings positions across companies. Swiss Life Asset Management Ltd increased its holdings in Honeywell International Inc. (HON) ($HON) and sold shares from several other companies, including West Pharma (WST), TE Connectivity Ltd ($TEL), and Swiss Life Asset Management's shares from State Street Corporation ($STT) to name a few. Securian Asset Management Inc. also modified its holdings in several companies, including West Pharmaceutical Services ($WST), Cummins Inc. ($CMI), Emerson Electric Co. ($EMR) On the other hand, Pier 88 Investment Partners LLC acquired a new stake in West Pharma ($WDC), while Win Advisors Inc. made a fresh investment in Western Digital Corp ($WDC). Furthermore, investors are awaiting the outcome of Chevron's shareholder proposal vote on May 27. ADL and JLens urge shareholders to reject Proposal 6, which they consider to be a 'controversial proposal'.

Related Stocks

Powered by SentiSense - Intelligent Market Analysis